feed,title,long_url,short_url
Benzinga,Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock,https://benzinga.com/analyst-ratings/analyst-color/24/02/37374868/enfusion-stock-to-remain-range-bound-in-2024-amid-stable-hedge-fund-market-goldman-,https://da.gd/qLSgUv
